Note: Descriptions are shown in the official language in which they were submitted.
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
COUPLING FOR AN AUTO-INJECTION DEVICE
CROSS REFERENCE TO RELATED APPLICATIONS
[0001]This application claims priority of U.S. Provisional Application Serial
No.
60/634,486 filed on December 9, 2004 and is related to commonly owned and
assigned U.S. Application Serial No. 10/601,212, filed June 20, 2003, the
contents of both of which are incorporated by reference herein.
BACKGROUND OF THE INVENTION
1. Field of the Invention
[0002]The present disclosure is related to auto-injection devices. More
particularly, the present disclosure is related to a coupling for auto-
injection
devices for releasably securing an injection spring to a plunger rod.
2. Description of Related Art
[0003] Diseases such as AIDS, Hepatitis, and others, are increasing within the
general population. The onset of these diseases has increased the desire to
prevent inadvertent needle sticks during the use of syringe assemblies. Many
prior art devices include self-retracting needles to mitigate inadvertent
needle
sticks.
[0004] Many life-threatening situations such as allergy induced anaphylactic
shock, and exposure to chemical, radiological, and biological weapons can
require the use of automatic injection devices. Also, many non-threatening
conditions can be candidates for use of such automatic injection devices.
However, the cost of the prior art automatic injection device can make such
use
by consumers cost prohibitive.
1
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
[0005]Typical automatic injection devices are syringe assemblies that allow
the
medically untrained user to automatically inject a medicine by manually
trigging
the automatic injection. Some prior automatic injection devices also
incorporate
self-retracting needles. Such automatic injection and retraction assemblies
included a coupling that releasably couples an injection spring to a syringe
plunger. Unfortunately, many prior couplings require tight manufacturing
tolerances, which can increase the overall cost of the device.
[0006]Accordingly, there is a continuing need for auto-injection devices and
couplings for such devices that overcome and/or mitigate one or more of the
aforementioned and other deficiencies and deleterious effects of prior
automatic
injection devices.
BRIEF SUMMARY OF THE INVENTION
[0007] It is an object of the present disclosure to provide a coupling for
selectively
securing a spring to a plunger. The coupling has a first end defining a spring
rest
for receiving the spring and a second end defining a shoulder. The shoulder is
moveable to a first position into contact with the plunger and to a second
position
out of contact with the plunger. The shoulder is normally in the second
position
and is resiliently moveable to the first position.
[0008] In some embodiments, the coupling includes a first end defining a
spring
rest for receiving the spring and a second end defining a shoulder. The spring
rest and the shoulder are radially offset from one another by a predetermined
angle.
[0009] In other embodiments, the coupling includes a first end defining a pair
of
spring rests for receiving the spring and a second end defining a pair of
2
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
shoulders. The pair of shoulders are moveable to a first position into contact
with
the plunger and a second position out of contact with the plunger.
[0010]A power injection assembly is also provided. The assembly includes a
plunger rod, an injection spring, an inner housing, and a coupling. The
plunger
rod has a rib. The inner housing has a first opening and an inner diameter.
The
injection spring is about the inner housing and the plunger rod is in the
inner
diameter. The coupling has a spring rest and a shoulder. The coupling is in
the
inner diameter such that the spring rest extends through the first opening and
receives the injection spring and such that the shoulder is compressed to a
first
position by the inner diameter. The shoulder is engaged with the rib in the
first
position.
[0011] The above-described and other features and advantages of the present
disclosure will be appreciated and understood by those skilled in the art from
the
following detailed description, drawings, and appended claims.
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
[0012] FIG. 1 is a perspective view of an exemplary embodiment of an auto-
injection device according to the present disclosure;
[0013] FIG. 2 is a perspective view of a power-injection assembly of FIG. 1
shown before assembly;
[0014] FIG. 3 is a perspective view of a power-retraction assembly of FIG. I
shown before assembly;
[0015] FIG. 4 is a first cross sectional view of the power-injection assembly
of
FIG. 2 taken along lines 4-4;
3
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
[0016] FIG. 5 is a second cross sectional view of the power-injection assembly
of
FIG. 2 taken along lines 5-5;
[0017] FIG. 6 is a view of the power-injection assembly of FIG. 5 shown after
activation;
[0018] FIG. 7 is a perspective view of an exemplary embodiment of a metal
spring to plunger coupling according to the present disclosure; and
[0019] FIG. 8 is a perspective view of an exemplary embodiment of an inner
housing according to the present disclosure.
DETAILED DESCRIPTION OF THE INVENTION
[0020] Referring to the figures and in particular to FIGS. 1 through 3, an
exemplary embodiment of an auto-injection device 10 according to the present
disclosure is shown in an assembled state. Auto-injection device 10 includes a
power-injection assembly 12, a medicine cartridge 14, and a power-retraction
assembly 16.
[0021]Auto-injection device 10 is configured to extend a hypodermic needle
from
within the device, inject a single, pre-measured dose of medicine from
cartridge
14 into a user, and automatically retract the hypodermic needle into the
device
after the injection is completed.
[0022]Advantageously, syringe assembly 10 is a multi-component device that
can be assembled by the user and/or medical provided (e.g., pharmacist,
doctor,
nurse). Since syringe assembly 10 does not require assembly at the time of
manufacture, the present disclosure effectively separates expiry of medicine
cartridge 14 from the expiry of syringe assembly 10. For example, typical flu
vaccines have an expiration date of one year. Thus, the user can maintain a
4
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
supply of power injection and retraction assemblies 12, 16 of the present
disclosure, while only replacing any expired medicine cartridges 14.
[0023] For example, power-injection assembly 12 and power-retraction assembly
16 can be secured to one another in a snap fit manner so that the assemblies
can not be removed from one another after injection. In the illustrated
embodiment, power-injection assembly 12 includes one or more outwardly
depending tabs 18 that are received in a corresponding number of openings 20
defined in power-retraction assembly 16. As power-injection assembly 12 is
inserted into power-retraction assembly 16, tabs 18 act on the power-
retraction
assembly to elastically deform the inner dimension of the tube. Once tabs 18
are
received by openings 20, the inner dimension of power-retraction assembly 16
resiliently returns to its original dimension to secure the tabs in the
openings.
[0024] In the assembled state, syringe assembly 10 preferably maintains
cartridge 14 hermetically sealed between power-injection and retraction
assemblies 12, 16. For example, power-injection assembly 12 can include a
sealing member 22 such as, but not limited to an o-ring. Once power-injection
assembly 12 and power-retraction assembly 16 are secured together, sealing
member 22 cooperates with the interior of the power-retraction assembly to
form
a hermetic radial seal. In the illustrated embodiment, sealing member 22 is
positioned below openings 20 defined in power-retraction assembly 16 to
provide
the hermetic seal below the snap fit connection between tabs 18 and openings
20.
[0025] The operation of the power-injection assembly 12 is described with
simultaneous reference to FIGS. 4 through 8. Injection assembly 12 includes an
injection spring 24, a plunger rod 26, an activation device 28, and a coupling
30
(FIG. 7). Injection spring 24 is disposed about plunger rod 26 and is
drivingly
engaged to the plunger rod by coupling 30.
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
[0026] Activation device 28 has an upper end 32 and a lower end 34. Injection
assembly 12 is activated by depressing activation device 28 in direction 48.
In
addition, activation device 28 can include an outer shroud 36. Outer shroud 36
and injection assembly 12 can include one or more cooperating guides (not
shown) that permit depression of activation device 28 only after the
activation
device has been rotated to a predetermined position. In sum, outer shroud 36
and injection assembly 12 can work together to require movement in two
directions, rotation and depression, in order to activate injection spring 24.
In a
preferred embodiment, shroud 36 includes a number of longitudinal ribs 38 to
assist the user in rotation. In this manner, injection assembly 12 is
particularly
suited for use in situations where the user may lack typical manual dexterity,
such as can be the case where the user is wherein protective gloves.
[0027] Lower end 34 is configured to selectively couple the energy from
injection
spring 24 to drive plunger rod 26. In the illustrated embodiment, plunger rod
26
includes a driving end 38 and a locking end 40. Locking end 40 includes two
tines 42 that are resiliently biased outward so that the tines are remote from
one
another. Driving end 38 is configured to act on medicine cartridge 14 in a
known
manner. For example, driving end 38 can act on medicine cartridge 14 as
described in U.S. Patent No. 6,387,078.
[0028] Injection assembly 12 includes a locking member 44 that engages tines
42
when the tines are normally biased from one another. Activation device 28
includes a releasing surface 46 defined at lower end 34. Force applied to
upper
end 32 of activation device 28 in direction 48 causes releasing surface 46 to
compress tines 42 toward one another such that the tines are disengaged from
locking member 44.
[0029] Injection spring 24 is maintained in a normally compressed or stressed
condition. Upon release of tines 42 from locking member 44, the stored energy
in spring 24 drives plunger rod 26 in an injection direction 48.
6
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
[0030] Coupling 30 includes a first end 50 and a second end 52. First end 50
forms a spring rest or seat 51 upon which injection spring 24 rests as shown
in
FIG. 4.
[0031]Second end 52 (shown in FIGS. 5 and 6) is an outwardly biased spring
member having a shoulder 53 for engaging plunger rod 26. During assembly,
second end 52 is compressed inward towards plunger rod 26 until shoulder 53
engages a rib 54 defined on plunger rod. Thus, second end 52 is moveable
between a compressed or first position (FIG. 5) and a normal or second
position
(FIG. 6). Second end 52 is normally in the second position, but has sufficient
resiliency such that the second end can be elastically urged to the first
position.
[0032] During movement of plunger rod 26 in injection direction 48, second end
52 is maintained in the compressed position and, thus, shoulder 53 is
maintained
engaged with rib 54 so that the force of injection spring 24 is transmitted
through
coupling 30 to plunger rod 26.
[0033]After plunger rod 26 has traveled a predetermined distance, second end
52 is allowed to bias outward away from rod 26 so that shoulder 53 disengages
from rib 54 as shown in FIG. 6. Thus, second end 52 moves from the
compressed position to the normal position due to its own resiliency once
plunger
rod 26 travels the predetermined distance to disengage shoulder 53 from rib
54.
Once shoulder 53 is disengaged from rib 54, the force of injection spring 24
is no
longer transmitted through coupling 30 to plunger rod 26.
[0034] Preferably, coupling 30 includes a pair of spring rests 51 and a pair
of
shoulders 53. Here, spring rests 51 are, preferably, diametrically opposed to
one
another. Similarly, shoulders 53 are, preferably, diametrically opposed to one
another. Moreover, spring rests 51 are, preferably, radially offset from
shoulders
7
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
53 by a predetermined angle, preferably about 90 degrees. In this manner, each
spring rest 51 is offset from each shoulder 53 by about by about 90 degrees.
[0035] Spring rests 51 are, preferably, axially offset from shoulders 53 by a
predetermined distance so that coupling 30 has an axial length. In this
manner,
spring rests 51 are disposed forward relative to shoulders 53 along the axial
length so that spring 24 encompasses a portion of the axial length.
[0036] For applications involving auto-injection devices 10 for small dose
volumes deposited at shallow depths, the demand on injection spring 24, in
terms of the spring rate and extension length, are not very severe. Thus,
injection spring 24 can be incorporated into power-injection assembly 12 with
a
reasonable set of device proportions (e.g., length and diameter). However, in
cases with auto-injection devices 10 that must deliver larger dose volumes
deposited at deeper needle penetration depths, the demand on injection spring
24, in terms of the spring rate and extension length, can be severe. In these
applications, injection spring 24 requires a long travel and high spring rate.
This
combination of high spring rate arid long travel typically requires injection
spring
24 to be a long, slender spring positioned in straight line sequence with the
plunger, which unfortunately leads to power-injection assembly 12 having an
undesireably long length. Alternately, the combination of high spring rate and
long travel typically requires injection spring 24 to have a large diameter.
[0037]Advantageously, coupling 30 is particularly suited for use with such
large
diameter springs. Specifically, coupling 30 has spring rests 51 that are
disposed
radially outward from the coupling and are disposed forward of shoulders 53.
In
this manner, injection spring 24 encompasses a portion of the axial length of
coupling 30 so that the larger diameter spring axially overlaps at least a
portion of
plunger rod 26. According, coupling 30 finds particular use with large
diameter
springs to mitigate the overall length of power-injection assembly 12.
8
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
[0038] In the illustrated embodiment, injection assembly 12 includes an inner
housing 56 shown in FIG. 8. Inner housing 56 defines has a first opening 58
through which spring rest 51 extends to engage injection spring 24. First
opening 58 extends along inner housing 56 in the injection direction 48.
Preferably, inner housing 56 has a pair of first openings 58 that are defined
through the inner housing diametrically opposed to one another to receive a
pair
of diametrically opposed spring rests 51.
[0039] Inner housing 56 has an inner diameter 60 that is sufficient to
maintain
second end 52 of coupling 30 in the compressed position and, thus, engaged
with plunger rod 26. Thus, second end 52 is outwardly biased against inner
diameter 60 of inner housing 56. The force of injection spring 24 is
sufficient to
overcome the friction between second end 52 and housing 56.
[0040] Inner housing 56 also includes a second opening 62. Preferably, inner
housing 56 has a pair of second openings 62 that are defined through the inner
housing diametrically opposed to one another. Second opening 62 is offset from
first opening 58 by the same predetermined angle that offsets spring rest 51
from
shoulder 53. Thus, second opening 62 is aligned with shoulder 53 of coupling
30.
[0041] Second opening 62 is defined at a predefined position along injection
direction 48 where it is desired for coupling 30 to disengage injection spring
24.
Thus, after plunger rod 26 has traveled to the point where second end 52 of
coupling 30 is at second opening 62, the second end 52 is no longer maintained
in the compressed position by inner diameter 60, which allows the second end
to
resiliently bias outward to the first position through the second opening and
move
shoulder 53 out of engagement with rib 54.
[0042]Advantageously, coupling 30 can be made of any niaterial having
sufficient resiliency to bias second end 52 outward at second opening 62. For
9
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
example, coupling 30 can be made of spring steel stamped into the desired
shape such as that illustrated in FIG. 7. Accordingly, coupling 30 can be made
less expensively and with lower manufacturing tolerances than previous
couplings.
[0043] In this manner, injection spring 24 drives plunger rod 26 in injection
direction 48 until second end 52 of coupling 30 reaches second opening 52. The
resiliency of coupling 30 causes the coupling to expand through second opening
52 and disengage shoulder 53 from rib 54 of plunger rod 26 as seen in FIG. 6.
The disengagement of coupling 30 from plunger rod 26 frees the plunger rod
from the force of injection spring 24 and, thus, allows the plunger rod to be
moved in a direction opposite injection direction 48 by retraction assembly
16.
[0044] Retraction assembly 16 can operate in a known manner. For example,
power-retraction assembly 16 can include a retraction spring (not shown) that
has a spring force lower than the spring force of injection spring 24. Thus,
injection spring 24 overcomes the force of the retraction spring as long as
coupling 30 engages plunger rod 26 to the injection spring. However, once
second end 52 of coupling 30 is disengaged from plunger rod 26 and the force
of
injection spring 24 is no longer transmitted through the coupling to the
plunger
rod, the force of the retraction spring is sufficient to urge medicine
cartridge 14 in
a direction opposite injection direction 48, thus automatically retracting the
hypodermic needle of cartridge 14 into device 10.
[0045] It should be noted that the terms "first", "second", "third", "upper",
"lower",
and the like may be used herein to modify various elements. These modifiers do
not imply a spatial, sequential, or hierarchical order to the modified
elements
unless specifically stated.
[0046] While the present disclosure has been described with reference to one
or
more exemplary embodiments, it will be understood by those skilled in the art
CA 02590281 2007-06-08
WO 2006/063123 PCT/US2005/044410
that various changes may be made and equivalents may be substituted for
elements thereof without departing from the scope of the present disclosure.
In
addition, many modifications may be made to adapt a particular situation or
material to the teachings of the disclosure without departing from the scope
thereof. Therefore, it is intended that the present disclosure not be limited
to the
particular embodiment(s) disclosed as the best mode contemplated, but that the
disclosure will include all embodiments falling within the scope of the
appended
claims.
11
